Wave Life Sciences Reports Third Quarter 2024 Financial Results …

Wave Life Sciences Reports Third Quarter 2024 Financial Results …

1 week from now

4 days ago  · Revenue recognized was ($7.7) million for the third quarter of 2024, as compared to $49.2 million in the third quarter of 2023, which included one-time revenue recognition events …

businessinsider.com

WAVE Life Sciences Ltd (WVE) Q3 2024 Earnings Call Highlights ...

1 week from now

3 days ago  · Research and Development Expenses:$41.2 million for Q3 2024, up from $31.6 million in the prior year quarter. General and Administrative Expenses:$15 million for Q3 2024, …

yahoo.com

WAVE Life Sciences Ltd (WVE) Q3 2024 Earnings Call Highlights ...

1 week from now

3 days ago  · General and Administrative Expenses: $15 million for Q3 2024, compared to $13.1 million in the prior year quarter. Net Loss: $61.8 million for Q3 2024, compared to net income …

gurufocus.com

Wave Life Sciences Third Quarter 2024 Earnings: Misses Expectations

1 week from now

2 days ago  · Wave Life Sciences Revenues and Earnings Miss Expectations. Revenue missed analyst estimates by 159%. Earnings per share (EPS) also missed analyst estimates by 62%. …

simplywall.st

Wave Life Sciences (WVE) Earnings Date And Reports 2024

1 week from now

1 day ago  · Consensus EPS. (Aug. 8) -$0.16. Wave Life Sciences issued Q2 2024 earnings on August 8, 2024, reporting an EPS of -$0.25, which missed the consensus estimate of -$0.16 …

marketbeat.com

ENDRA Life Sciences Reports Third Quarter 2024 Financial Results …

1 week from now

1 day ago  · Third Quarter 2024 Financial Results Operating expenses in the third quarter of 2024 were down 52% to $1.5 million compared with $3.1 million in the third quarter in 2023, and …

morningstar.com

SELLAS Life Sciences Reports Third Quarter 2024 Financial

1 week from now

3 days ago  · Financial Results for the Third Quarter 2024: R&D Expenses : Research and development expenses for the quarter ended September 30, 2024 , were $4.4 million , …

nasdaq.com

Kezar Life Sciences Reports Third Quarter 2024 Financial

1 week from now

3 days ago  · Research and development (R&D) expenses for the third quarter of 2024 decreased by $7.5 million to $16.2 million, compared to $23.7 million in the third quarter of 2023. This …

biospace.com

ENDRA Life Sciences Reports Third Quarter 2024 Financial

1 week from now

1 day ago  · Net loss in the third quarter of 2024 was $2.4 million, compared with a net loss of $3.1 million in the third quarter of 2023. However, the third quarter 2024 loss included a net non …

biospace.com

Wave Life Sciences Reports Second Quarter 2024 Financial Results …

1 week from now

Aug 8, 2024  · Net loss was $32.9 million for the second quarter of 2024, as compared to $21.1 million for the second quarter of 2023. Wave will host an investor conference call today at 8:30 …

yahoo.com

Wave Life Sciences Reports Third Quarter 2022 Financial Results …

1 week from now

Nov 10, 2022  · Third Quarter 2022 Financial Results and Financial Guidance Wave reported a net loss of $39.0 million in the third quarter of 2022, as compared to $6.2 million in the same …

wavelifesciences.com

TriSalus Reports Q3 2024 Financial Results And Provides ... - Nasdaq

1 week from now

2 days ago  · TriSalus Reports Q3 2024 Financial Results and Provides Business Update. Published. Nov 14, 2024 8:00am EST. – Reported Q3 and nine-month revenues of $7.3 …

nasdaq.com

ENDRA Life Sciences Reports Third Quarter 2024 Financial Results …

1 week from now

Sep 30, 2024  · Third Quarter 2024 Financial Results. Operating expenses in the third quarter of 2024 were down 52% to $1.5 million compared with $3.1 million in the third quarter in 2023, …

stockhouse.com